Dr. Vicente Torres, MD

• Nephrology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Autonomous University Of Barcelona / Faculty Of Medicine

  Medical School

• Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease, 2013-12-15

• Autosomal Dominant Polycystic Kidney Disease (ADPKD): Executive Summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, 2015-03-18

• Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial, 2016-11-14

• Reactive Oxygen Species and Redox Signaling in Chronic Kidney Disease, 2020-05-28

• GTP-binding of ARL-3 is activated by ARL-13 as a GEF and stabilized by UNC-119, 2016-04-22

• Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease - Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?, 2018-04-10

• Semantic Instance Segmentation of Kidney Cysts in MR Images: A Fully Automated 3D Approach Developed Through Active Learning, 2021-04-05

• Autosomal dominant polycystic kidney disease: the last 3 years, 2009-05-20

• Renal Arterial Blood Flow Measurement by Breath-held MRI: Accuracy in Phantom Scans and Reproducibility in Healthy Subjects, 2013-07-24

• Evidence of a third ADPKD locus is not supported by reanalysis of designated PKD3 families, 2013-06-12

• Transition fibre protein FBF1 is required for the ciliary entry of assembled intraflagellar transport complexes, 2013-11-30

• Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease, 2017-02-07

• Generation and phenotypic characterization ofPde1amutant mice, 2017-07-27

• Incompletely penetrantPKD1alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease, 2009-01-21

• Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort, 2018-12-27

• Multiple unilateral subcapsular cortical hemorrhagic cystic disease of the kidney: CT and MRI findings and clinical characteristic, 2019-02-26

• Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease, 2017-12-28

• Three-dimensional NMR microscopy of zebrafish specimens, 2018-11-15

• Semiautomated Segmentation of Polycystic Kidneys in T2-Weighted MR Images, 2016-06-24

• Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial, 2017-02-20

• GermlinePKHD1mutations are protective against colorectal cancer, 2011-01-28

• Oxidative Stress and Mitochondrial Abnormalities Contribute to Decreased Endothelial Nitric Oxide Synthase Expression and Renal Disease Progression in Early Experimental Polycystic Kidney Disease, 2020-03-14

• Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease, 2020-11-02

• The genetic background significantly impacts the severity of kidney cystic disease in thePkd1RC/RCmouse model of autosomal dominant polycystic kidney disease, 2021-03-09

• Effect of a Vasopressin V2 Receptor Antagonist on Polycystic Kidney Disease Development in a Rat Model, 2019-05-22

• Tolvaptan in ADPKD Patients With Very Low Kidney Function, 2021-06-09

• Cardiovascular Consequences of New-Onset Hyperglycemia After Kidney Transplantation, 2012-08-27

• OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD, 2023-02-13

• The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family WithPKD2andCOL4A1Mutations, 2018-02-01

• The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD, 2022-08-27

• Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS, 2019-01-15

• Effect of statin therapy on the progression of autosomal dominant polycystic kidney disease. A secondary analysis of the HALT PKD trials, 2017-11-02

• Congenital Heart Disease in Adults with Autosomal Dominant Polycystic Kidney Disease, 2022-03-21

• Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome, 2008-09-24

• Pasireotide is more effective than Octreotide in reducing hepato-renal cystogenesis in rodents with polycystic kidney and liver diseases, 2013-03-06

• A comparison of ultrasound and magnetic resonance imaging shows kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease, 2015-04-01

• Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, 2019-07-29

• Long-term trajectory of kidney function in autosomal dominant polycystic kidney disease, 2019-03-04

• Polycystic kidney disease, 2018-12-06

• Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials, 2018-01-03

• Impaired Hedgehog-GLI1 pathway activity underlies the vascular phenotype of Polycystic Kidney Disease, 2020-10-05

• The importance of total kidney volume in evaluating progression of polycystic kidney disease, 2016-10-03

• Alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a pooled analysis, 2015-11-09

• Characteristics of Renal Cystic and Solid Lesions Based on Contrast-Enhanced Computed Tomography of Potential Kidney Donors, 2012-03-06

• Utilizing Magnetization Transfer Imaging to Investigate Tissue Remodeling in a Murine Model of Autosomal Dominant Polycystic Kidney Disease, 2015-05-13

• Pancreatic Cysts and Intraductal Papillary Mucinous Neoplasm in Autosomal Dominant Polycystic Kidney Disease, 2019-04-02

• Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease, 2010-11-01

• Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease, 2019-03-09

• Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease., 2019-10-09

• Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study, 2013-01-10